64% of Cyber Weekend Buyers Say Rising Prices Impacted Their Shopping; 56% Shopped Primarily or Exclusively Online, Numerator Reports Apparel & Shoes, Beauty Products, and Groceries Most Purchased Categories; Amazon Attracted 87% of Holiday Weekend Shoppers GlobeNewswire December 02, 2025 CHICAGO, Dec. 02, 2025 (GLOBE NEWSWIRE) — Numerator, a data and tech company serving the […]

(NASDAQ:PRFX), TEL AVIV, Israel, Dec. 02, 2025 (GLOBE NEWSWIRE) — PainReform Ltd. (Nasdaq: PRFX) today announced, through its pharmaceutical division, the commencement of its development plan for OcuRing(TM)-K, LayerBio's patented, drop-less, intraoperatively administered sustained-release ocular therapy designed to deliver controlled, site-specific release of ketorolac following cataract surgery. Following the closing of PainReform's majority investment in

(TSX:DBM),(TSX:DBM-NT), THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) — Doman Building Materials Group Ltd. (“Doman” or the “Company“) (TSX: DBM) announced today that it has closed its

(NASDAQ:ASPI),(Johannesburg:ASPI), WASHINGTON, Dec. 02, 2025 (GLOBE NEWSWIRE) — ASP Isotopes Inc. NASDAQ: ASPI (“ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that, effective January 19, 2026, Paul Mann, the founder and Executive Chairman of

(NASDAQ:IPST), GIG HARBOR, Wash., Dec. 02, 2025 (GLOBE NEWSWIRE) — IP Strategy (Nasdaq: IPST) (the “Company”), the first company to adopt a treasury reserve policy centered on the $IP token, releases its monthly publication detailing its validator business performance and broader ecosystem developments for tokenized intellectual property and AI-native data networks. The report is part

(NASDAQ:LGVN),(NASDAQ:LGVNR), The patent relates to methods of administering therapeutically effective amounts of isolated allogeneic mesenchymal stem cells (MSCs) to patients with aging-related frailty with inflammaging and also to treat patients with non-ischemic dilated cardiomyopathy Non-ischemic dilated cardiomyopathy is a progressive disorder with no current cure, often leading to heart transplantation No approved treatments for aging-related

(NASDAQ:EDBL),(NASDAQ:EDBLW), BELVIDERE, NJ, Dec. 02, 2025 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leading provider of controlled environment agriculture (CEA) solutions and sustainable, locally grown organic produce, today announced that it will participate in the 2025 New York Produce Show and Conference, taking place December 3,

(NasdaqGM:CYCU),(NASDAQ:CYCUW), MCLEAN, Va., Dec. 02, 2025 (GLOBE NEWSWIRE) — Cycurion, Inc. (“Cycurion” or the “Company”) (NASDAQ: CYCU), a publicly traded leader in technology and staffing solutions for the public sector, is proud to announce that it has been officially awarded a position on the State of Florida's Management Consulting Services State Term Contract, as outlined

(NASDAQ:CELZ), PHOENIX, Dec. 02, 2025 (GLOBE NEWSWIRE) — Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage biotechnology company developing next-generation regenerative and immune cell therapies, today announced that the World Health Organization (WHO) has approved “olastrocel” as the International Non-Proprietary Name (INN) for the active cellular substance in CELZ-201,

PainReform Commences Development for OcuRing(TM)-K Phase II Trial, LayerBio's Drop-Less Sustained-Release Ocular Therapy Development plan positions OcuRing(TM)-K for advancement in the fast-growing, multi-billion-dollar global cataract surgery market GlobeNewswire December 02, 2025 TEL AVIV, Israel, Dec. 02, 2025 (GLOBE NEWSWIRE) — PainReform Ltd. (Nasdaq: PRFX) today announced, through its pharmaceutical division, the commencement of its development